Table 5 Adherence and viral load suppression in HIV-TB co-infected patients and patients on second-line ART
| Â | HIV-TB co-infected patients | Patients switched to second-line ART | ||||
|---|---|---|---|---|---|---|
6 month period before TB treatment, n (%) | During TB treatment, n(%) | 6 month period before regimen change, n(%) | 6 months after regimen change, n(%) | 6 month period before regimen change, n(%) | 12 months after regimen changea, n(%) | |
Mean ART adherence | ||||||
 < 95% | 0 (0) | 3 (18) | 7 (33) | 2 (10) | 7 (33) | 0 |
 ≥ 95% | 17 (100) | 14 (82) | 14 (67) | 19 (90) | 14 (67) | 19 (90) |
p-value | 0.250 | 0.180 | 0.016 | |||
Viral load | ||||||
 ≥ 400 copies/mL | 2 (12) | 3 (18) | 21 (100) | 5 (24) | 21 (100) | 1 (5) |
 < 400 copies/mL | 15 (88) | 14 (82) | 0 (0) | 16 (76) | 0 (0) | 19 (90) |
p-value | 0.563 | < 0.0001 | < 0.0001 | |||